Scarica l'app Stockscreener
2.99
2.40%
0.07
Precedente Chiudi:
$2.92
Aprire:
$2.88
Volume 24 ore:
2.42M
Relative Volume:
1.65
Capitalizzazione di mercato:
$343.42M
Reddito:
$4.21M
Utile/perdita netta:
$-97.67M
Rapporto P/E:
-2.4508
EPS:
-1.22
Flusso di cassa netto:
$-70.76M
1 W Prestazione:
-19.08%
1M Prestazione:
+11.57%
6M Prestazione:
+2.40%
1 anno Prestazione:
-2.29%
Intervallo 1D:
$2.86
$3.085
Intervallo di 1 settimana:
$2.7925
$4.11
Portata 52W:
$2.45
$6.72
Absci Corp Stock (ABSI) Company Profile
Nome
Absci Corp
Settore
Industria
Telefono
(360) 949-1041
Indirizzo
18105 SE MILL PLAIN BLVD, VANCOUVER
Confronta ABSI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.99 | 343.42M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-02 | Iniziato | Guggenheim | Buy |
| 2024-07-03 | Iniziato | Morgan Stanley | Overweight |
| 2024-03-14 | Iniziato | Scotiabank | Sector Outperform |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2022-08-12 | Downgrade | JP Morgan | Overweight → Underweight |
| 2022-07-18 | Iniziato | Truist | Buy |
| 2022-03-02 | Ripresa | Cowen | Market Perform |
| 2022-02-01 | Iniziato | Berenberg | Buy |
| 2021-11-10 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-08-16 | Iniziato | BofA Securities | Neutral |
| 2021-08-16 | Iniziato | Cowen | Market Perform |
| 2021-08-16 | Iniziato | Credit Suisse | Outperform |
| 2021-08-16 | Iniziato | Stifel | Hold |
Mostra tutto
Absci Corp Borsa (ABSI) Ultime notizie
Generative AI vs. cancer: Absci partners with Memorial Sloan Kettering for new therapeutics - MSN
Absci shares reiterated at Buy at H.C. Wainwright following R&D day - Investing.com
Absci shares reiterated at Buy at H.C. Wainwright following R&D day By Investing.com - Investing.com UK
Wilmington Savings Fund Society FSB Acquires New Holdings in Absci Co. (NASDAQ:ABSI) - MarketBeat
Charles Schwab Investment Management Inc. Grows Position in Absci Co. (NASDAQ:ABSI) - Defense World
Verition Fund Management LLC Takes Position in Absci Co. (NASDAQ:ABSI) - Defense World
Absci Co. (NASDAQ:ABSI) Receives $8.67 Average Target Price from Analysts - MarketBeat
Absci Co. (NASDAQ:ABSI) Receives Consensus Rating of “Buy” from Analysts - Defense World
Absci (NASDAQ:ABSI) Given Buy Rating at HC Wainwright - MarketBeat
Absci highlights progress, updates across proprietary pipeline - Yahoo Finance
Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day - GlobeNewswire
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket - Benzinga
United Natural Foods Posts Upbeat Results, Joins Alphabet, Ollie's Bargain, MoneyLion And Other Big Stocks Moving Higher On Tuesday - Benzinga
Wall Street Analysts Were Busy This Morning - MSN
Absci Corporation (NASDAQ:ABSI) is favoured by institutional owners who hold 56% of the company - Yahoo Finance
Absci initiated with a Buy at JonesResearch - MSN
Cathie Wood's ARK buys Absci stock, sells Butterfly and Senti By Investing.com - Investing.com Nigeria
Cathie Wood's ARK buys Absci stock, sells Butterfly and Senti - Investing.com India
Absci a new buy at Jones on AI platform to design antibodies - Seeking Alpha
KBW Bank Index (BKX) QuotePress Release - The Globe and Mail
TSX Health Care Capped Index (TTHC) QuotePress Release - The Globe and Mail
Jones Trading bullish on Absci stock, highlights unique AI platform & pharma deals - Investing.com
TSX Financials Capped Index (TTFS) QuotePress Release - The Globe and Mail
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
S&P 500 ESG (ESG) QuotePress Release - The Globe and Mail
Victory Capital Management Inc. Has $575,000 Stock Position in Absci Co. (NASDAQ:ABSI) - Defense World
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference - Yahoo Finance
Absci Co. (NASDAQ:ABSI) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Portland InnoA founder's return | Absci heads to Europe - The Business Journals
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care - Benzinga
Absci Corporation: Struggling To Live Up To Its AI Promise (NASDAQ:ABSI) - Seeking Alpha
HC Wainwright Has Negative Outlook of Absci FY2024 Earnings - MarketBeat
Absci Corporation (NASDAQ:ABSI) Q3 2024 Earnings Call Transcript - Insider Monkey
FMR LLC Acquires Significant Stake in Absci Corp - GuruFocus.com
Absci Corporation Advances AI-Driven Drug Development - TipRanks
Absci earnings missed by $0.05, revenue fell short of estimates - Investing.com South Africa
Absci Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Absci Corporation (ABSI) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results - Yahoo Finance
Earnings Scheduled For November 12, 2024 - Benzinga
Absci Corp (ABSI) Q3 2024 Earnings Report Preview: What to Look For - GuruFocus.com
Absci (ABSI) Set to Announce Earnings on Tuesday - Defense World
4 Biotech Stocks With AI, Machine Learning Prowess - Head Topics
Absci to Host R&D Day on December 12, 2024 - Yahoo Finance
Absci Sets AI Drug Innovation Showcase at 2024 R&D Day Event - StockTitan
I: Exploring 🧭 TechBio - substack.com
Absci (ABSI) Scheduled to Post Earnings on Tuesday - MarketBeat
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI - Yahoo Finance
Absci Co. (NASDAQ:ABSI) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Absci to Participate in Upcoming Investor Conferences - Yahoo Finance
You might want to take a look at Absci Corp (ABSI) now - SETE News
Absci Corp Azioni (ABSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Absci Corp Azioni (ABSI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Jonasson Zachariah | CFO / CBO |
Jun 13 '24 |
Sale |
4.98 |
19,859 |
98,892 |
384,751 |
| Phoenix Venture Partners II LP | 10% Owner |
May 22 '24 |
Sale |
4.40 |
3,100,000 |
13,640,000 |
11,279,522 |
| Redmile Group, LLC | Director |
Mar 01 '24 |
Buy |
4.50 |
222,222 |
999,999 |
8,253,316 |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):